Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

BBIOBBIO

Showing 8 of 29 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in BRIDGEBIO PHARMA INC

Yes. Viking Global Investors holds 9,949,219 shares of BBIO (Bridgebio Pharma), worth $741M, as of its Q2 2026 13F filing. It reduced the position by 1,893,215 shares (-16.0%) from Q1 2026. Viking Global Investors has held BBIO since Q2 2019, across 29 quarterly 13F filings. BBIO is 2.1% of Viking Global Investors' reported 13F portfolio.

Current Value

$741M

Current Shares

9.9M

Total Value Change

+$101.4M

Total Shares Change

-15.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
9.9M
-16.0%
$741M2.1%$74.48
0
2026-Q1
Decreased
11.8M
-17.7%
$879.4M2.5%$74.26
0
2025-Q4
Decreased
14.4M
-9.9%
$1.1B2.9%$76.49
0
2025-Q3
Decreased
16M
-13.9%
$829.9M2.2%$51.94
0
2025-Q2
Decreased
18.6M
-15.9%
$801.2M2.3%$43.18
0
2025-Q1
Decreased
22.1M
-12.2%
$762.5M2.4%$34.57
0
2024-Q4
Unchanged
25.1M
0.0%
$689.3M2.2%$27.44
0
2024-Q3
Unchanged
25.1M
0.0%
$639.6M2.3%$25.46
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used